```html

Vasculitic Purpura

What is Vasculitic Purpura?

Vasculitic purpura is a type of skin bleeding that occurs when small blood vessels (capillaries, venules, or arterioles) become inflamed and damaged. The inflammation, called vasculitis, weakens the vessel walls so that red blood cells leak into the surrounding tissue, producing reddish‑purple spots that do not blanch when pressed. These spots are called purpura. When vasculitis is the underlying cause, the condition is referred to as “vasculitic purpura.”

Purpura can range from tiny, pinpoint petechiae (<5 mm) to larger, raised lesions (palpable purpura) that may be painful or itchy. Because the skin is easily visible, vasculitic purpura often serves as the first clue that a systemic inflammatory process is occurring elsewhere in the body.

Most cases are benign and self‑limited, but some signal a serious underlying disease that requires prompt evaluation. (Sources: Mayo Clinic; National Institute of Arthritis and Musculoskeletal and Skin Diseases – NIAMS).

Common Causes

Vasculitic purpura can be triggered by many conditions. The most frequent are:

• IgA Vasculitis (Henoch‑Schönlein Purpura) – an immune complex disease that commonly affects children.
• Leukocytoclastic (Small‑Vessel) Vasculitis – often drug‑induced or infection‑related.
• COVID‑19–associated vasculitis – viral infection can provoke immune‑mediated vessel injury.
• Systemic Lupus Erythematosus (SLE) – an autoimmune disease that can cause cutaneous and systemic vasculitis.
• ANCA‑Associated Vasculitis (e.g., microscopic polyangiitis, granulomatosis with polyangiitis).
• Cryoglobulinemia – usually linked to hepatitis C infection.
• Infections – streptococcal pharyngitis, endocarditis, hepatitis B/C, HIV.
• Medications – antibiotics (penicillins, cephalosporins), NSAIDs, allopurinol, thiazide diuretics.
• Malignancies – especially hematologic cancers like lymphoma or leukemia.
• Sneddon syndrome – a rare combination of livedo racemosa and cerebrovascular events.

Associated Symptoms

The presence of additional signs helps identify the underlying cause and the extent of disease:

• Joint pain or swelling – common in IgA vasculitis and SLE.
• Abdominal pain, vomiting, or bloody stools – suggest gastrointestinal involvement (IgA vasculitis or leukocytoclastic vasculitis).
• Kidney problems – hematuria, proteinuria, or swelling (IgA vasculitis, ANCA‑associated vasculitis, lupus).
• Fever, chills, or malaise – indicate systemic inflammation or infection.
• Neurologic symptoms – headaches, confusion, or peripheral neuropathy (cryoglobulinemia, Sneddon syndrome).
• Respiratory symptoms – cough, shortness of breath, or hemoptysis (microscopic polyangiitis, granulomatosis with polyangiitis).
• Skin changes – palpable purpura, livedo reticularis, ulceration, or necrosis.
• Weight loss – may point to an underlying malignancy or chronic inflammatory disease.

When to See a Doctor

Because vasculitic purpura can be a sign of a serious systemic disease, contact a health professional promptly if you notice:

• Purpura that spreads rapidly or becomes painful/ulcerated.
• Accompanying fever, unexplained weight loss, or night sweats.
• Swelling, pain, or blood in the urine (possible kidney involvement).
• Abdominal pain, especially with vomiting or blood in the stool.
• Persistent joint swelling or severe joint pain.
• Shortness of breath, coughing up blood, or chest pain.
• Neurologic changes such as numbness, weakness, or confusion.

Even if the rash appears mild, a dermatologist or primary‑care physician should evaluate it to rule out systemic vasculitis.

Diagnosis

Diagnosing vasculitic purpura involves a stepwise approach that combines history, physical examination, laboratory studies, imaging, and sometimes a skin biopsy.

1. Detailed Medical History

• Recent infections, new medications, or vaccinations.
• Previous episodes of rash or systemic disease.
• Family history of autoimmune disorders.
• Travel history or exposure to ticks, insects, or chemicals.

2. Physical Examination

• Distribution, size, and palpability of purpuric lesions.
• Examination of joints, abdomen, lungs, and neurological status.
• Assessment for livedo racemosa, urticaria, or other skin findings.

3. Laboratory Tests

• Complete blood count (CBC) – to detect anemia, leukocytosis, or thrombocytopenia.
• Erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP) – markers of inflammation.
• Urinalysis – checks for hematuria or proteinuria.
• Serum creatinine and BUN – assess kidney function.
• Complement levels (C3, C4) – often low in immune‑complex vasculitis.
• Autoantibodies: ANA, anti‑dsDNA (lupus), ANCA (c‑ANCA, p‑ANCA), anti‑GBM.
• IgA level – elevated in IgA vasculitis.
• Hepatitis B & C serologies, HIV test – infections linked to vasculitis.
• Cryoglobulin testing if cryoglobulinemic vasculitis is suspected.

4. Skin Biopsy

 A punch or excisional biopsy of a fresh (<24‑48 h) palpable purpuric lesion is the gold standard. Histology typically shows:

• Leukocytoclastic vasculitis – neutrophilic infiltrate, fibrinoid necrosis of vessel walls, nuclear debris.
• Immunofluorescence may reveal IgA, IgM, or C3 deposition, helping differentiate specific entities.

5. Imaging (when indicated)

• Chest X‑ray or CT scan – for pulmonary involvement.
• Renal ultrasound – if kidney disease is suspected.
• Angiography – for medium‑vessel vasculitis (e.g., polyarteritis nodosa).

6. Additional Specialized Tests

In refractory or atypical cases, a referral to a rheumatologist, nephrologist, or hematologist may be needed for advanced work‑up such as bone‑marrow biopsy or genetic testing.

Treatment Options

Treatment is tailored to the underlying cause, severity of skin involvement, and presence of systemic disease.

General Measures (Home Care)

• Rest and elevation of affected limbs to reduce swelling.
• Cool compresses (not ice) to relieve pain or itching.
• Avoid trauma to the rash – gentle skin care, loose clothing.
• Stop any suspected offending drug after consulting a physician.
• Maintain good hydration and a balanced diet to support vascular health.

Pharmacologic Therapy

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) – useful for mild joint pain; avoid if renal involvement is present.
• Systemic corticosteroids (prednisone 0.5‑1 mg/kg/day) – first‑line for moderate‑to‑severe vasculitis or organ involvement.
• Immunosuppressive agents (azathioprine, methotrexate, cyclophosphamide, mycophenolate mofetil) – for refractory disease or ANCA‑associated vasculitis.
• Biologic agents – rituximab (anti‑CD20) for ANCA vasculitis or severe IgA vasculitis; anti‑TNF agents for vasculitis linked to inflammatory bowel disease.
• Colchicine – sometimes used for mild leukocytoclastic vasculitis.
• Plasmapheresis – reserved for life‑threatening organ involvement (e.g., rapidly progressive glomerulonephritis).
• Antibiotics or antiviral therapy – when an underlying infection such as hepatitis C or bacterial endocarditis is identified.

Supportive Care

• Kidney protection – ACE inhibitors or ARBs if proteinuria is present.
• Anticoagulation is generally avoided because of bleeding risk, unless there is a coexisting thrombotic disorder.
• Physical therapy for joint stiffness after inflammation subsides.

Prevention Tips

While many vasculitic triggers cannot be completely avoided, certain strategies can lower risk:

• Take antibiotics and other prescription drugs only as directed; inform your doctor of any prior drug reactions.
• Stay up to date with vaccinations, especially influenza and COVID‑19, to reduce infection‑related vasculitis.
• Practice good hand hygiene and avoid exposure to known infectious agents (e.g., tick‑borne illnesses).
• Manage chronic conditions (diabetes, hypertension, hepatitis C) with regular medical care.
• Limit alcohol and avoid illicit drug use, which can precipitate vasculitis.
• Maintain a healthy weight and regular exercise to support vascular integrity.
• For patients with known autoimmune disease, adhere to maintenance therapy and routine follow‑up to catch flares early.

Emergency Warning Signs

Bottom Line

Vasculitic purpura is more than a skin rash—it often signals inflammation of tiny blood vessels that may involve kidneys, lungs, gastrointestinal tract, or nerves. Early recognition, thorough evaluation, and targeted therapy are key to preventing complications. If you develop unexplained purpura, especially with systemic symptoms, contact a health professional promptly.

References:

• Mayo Clinic. “Purpura.” https://www.mayoclinic.org
• NIH – National Institute of Arthritis and Musculoskeletal and Skin Diseases. “Vasculitis.” https://www.niams.nih.gov
• American College of Rheumatology. “Guidelines for the Management of Vasculitis.” Arthritis Care & Research, 2021.
• CDC. “Hepatitis C and Cryoglobulinemic Vasculitis.” https://www.cdc.gov
• WHO. “COVID‑19 Clinical Management.” https://www.who.int
• Cleveland Clinic. “IgA Vasculitis (Henoch‑Schönlein Purpura).” https://my.clevelandclinic.org

```